Simplify has just announced the launch of a new thematic ETF focused on the health industry. The Simplify Propel Opportunities ETF (SURI) is available for trade on the NYSE looking to offer exposure to companies with the health science industry that are overlooked by investors. SURI plans to do this through a multi-asset strategy giving at least 25% of its net assets to pharma, biotech, healthcare technologies, and life science companies. SURI will be sub-advised by Propel and will invest across market caps, countries, and currencies.
ETF Newz Says:
As of launch SURI’s top three holdings are, Plains All American Pipeline (22.11%), Athira Pharma Inc (7.16%), and the SPDR Bloomberg Barclays Investment Grade Floating Rate ETF (5.72%).
